GENEVA—The potential for using vaccines as important weapons against non small cell lung cancer has not yet been realized according to Johan Vansteenkiste MD PhD, an oncologist and professor of medici
GENEVA—The potential for using vaccines as important weapons against non small cell lung cancer has not yet been realized according to Johan Vansteenkiste MD PhD, an oncologist and professor of medicine at University Hospitals Leuven in Belgium. After his talk at the 2015 European Lung Cancer Conference he told Oncology Times reporter Peter Goodwin that his group’s findings in the MAGRIT trial using the MAGE-A3 vaccine did not raise hopes that vaccination could yet be regarded as an independent therapy but that combining immune-based therapies—to include the so-called: “check point inhibitors” and release the brakes on natural immunity imposed by cancer—could be an enabling strategy.